期刊文献+

不同配方哌仑西平滴眼液的兔角膜通透性的实验研究 被引量:6

Corneal permeability of topically applied pirenzepine solution
原文传递
导出
摘要 目的探讨不同配方哌仑西平滴眼液的角膜通透性,为临床应用提供依据。方法配制2%哌仑西平滴眼液(单纯哌仑西平组)、2%哌仑西平+0.1%透明质酸钠滴眼液(透明质酸钠组)及2%哌仑西平+0.1%氮酮滴眼液(氮酮组)。将63只新西兰白兔分为3组,分别在各组兔双眼结膜囊内滴入上述眼液,滴眼6次,每次间隔5min。在最后1次滴眼后0.5、1·0、2·0、4·0、8·0、12·0、24·0h抽取前房水约0.2ml,使用高效液相色谱仪分析前房水中哌仑西平的浓度,并于每次滴眼前后和穿刺抽吸房水前用裂隙灯显微镜观察3组兔眼部的一般情况。结果最后1次滴眼后0.5、1·0、2·0、4·0h单纯哌仑西平组前房水中哌仑西平的浓度分别为(0.40±0.06)、(0.53±0.03)、(1.52±0.33)及(0.15±0.02)μg/ml,8·0h后高效液相色谱仪未能检测到哌仑西平。各时间点氮酮组和透明质酸钠组前房内哌仑西平浓度均明显高于单纯哌仑西平组(P<0.01),生物利用度分别约是其23·0倍和3.4倍。并且实验过程中各组兔眼部均无刺激症状。结论氮酮组的角膜通透性最好,透明质酸钠组次之,均显著高于单纯哌仑西平组,表明氮酮和透明质酸钠均可用于哌仑西平滴眼液中,为临床应用提供了新的思路。 Objective To study the corneal permeability of three different pirenzepine eye-drop solutions and provide reference for further clinical use. Methods Sixty-three New Zealand white rabbits were divided into three groups. Each group of rabbits received 2% pirenzepine ( pirenzepine group), 2% pirenzepine with 0. 1% hyalurnnic acid (hyalurnnic acid group), or 2% pirenzepine with 0. 1% azone (azone group). One drop eye-drops was applied to conjunctive sac every 5 min for six times. Aqueous samples were obtained from each group at 0.5,1.0,2.0,4.0,8.0,12.0,24.0 h after the last drop, respectively. Concentration of pirenzepine in these samples was determined by the HPLC (high pressure liquid chromatography). Stimulation symptom of rabbit eyes was also observed. Results The concentrations of pirenzepine in aqueous humor were (0. 40 ± 0.06 ) μ/ml at 0.5 h, (0.53 ± 0.03 ) μ/ml at 1.0 h, ( 1.52 ± 0.33 )μg/ml at 2. 0 h and (0. 15 ± 0.02) μg/ml at 4. 0 h in pirenzepine group. Aqueous humor concentration of pirenzepine in both 2% pirenzepine with 0. 1% azone and 2% pirenzepine with 0. 1% hyalurnnic acid were significantly higher than that of single pirenzepine application, and their bioavailability in the groups with combinations of pirenzepine with 0.1% azone or 0.1% hyalurnnic acid were 23.0 times and 3.4 times higher than that of single pirenzepine usage. No obvious irritate symptom was found in rabbit of all three groups after eye-drop applying. Conclusions The combination application of pirenzepine with azone or hyalurnnic acid has higher corneal permeability compared with pirenzepine alone. This result indicates that azone and hyalurnnic acid could be used in pirenzepine eye-drop solution to increase corneal permeability. (Chin J Ophthalmol , 2006,42: 531-534)
出处 《中华眼科杂志》 CAS CSCD 北大核心 2006年第6期531-534,共4页 Chinese Journal of Ophthalmology
关键词 近视 哌仑西平 透明质酸钠 眼药水 通透性 Myopia Pirenzepine Hyalurnnic acid Ophthalmic solutions Permeability
  • 相关文献

参考文献10

  • 1Stone RA,Lin T,Laties AM.Muscarinic antagonist effects on experimental chick myopia.Exp Eye Res,1991,52:755-758. 被引量:1
  • 2Cottriall CL,McBrien NA.The Mi muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew.Invest Ophthalmol Vis Sci,1996,37:1368-1379. 被引量:1
  • 3Siatkowski R.Pirenzepine 2% ophthalmic gel retards myopic progression in 8-12 year old children.Invest Ophthalmol Vis Sci,2003,44:4778. 被引量:1
  • 4Bartlett JD,Niemann K,Houde B,et al.Safety and tolerability of pirenzepine ophthalmic gel in pediatric myopia patients.Invest Ophthalmol Vis Sci,2000,41 (suppl):303. 被引量:1
  • 5Stoughton RB,McClure WD.Azone:a new non toxic enhancer of percutaneous penetration.Drug Dev Ind Pharm,1983,9:725-744. 被引量:1
  • 6Tang-liu DD,Richman JB,Weinkam R J,et al.Effect of four penetration enhancers on corneal permeability of drugs in vitro.J Pharm Sci,1994,83:85-90. 被引量:1
  • 7Cottriall CL,McBrien NA,Annies R,et al.Prevention of formdeprivation myopia with pirenzepine:a study of drug delivery and distribution.Ophthalmic Physiol Opt,1999,19:327-335. 被引量:1
  • 8Newton C,Gebhardt BM,Kaufman HE.Topically applied cyclosporine in azone prolongs corneal allograft survival.Invest Ophthalmol Vis Sci,1988,29:208-215. 被引量:1
  • 9Durand-Cavagna G,Duprat P,Molon-Noblot S,et al.Corneal endothelial changes with azone,a penetration enhancer.Lens Eye Toxic Res,1989,6:109-117. 被引量:1
  • 10徐岩,陈祖基,宋洁贞,靳伟民,李建新.高效皮肤渗透促进剂-氮酮对角膜内皮的影响[J].中华眼科杂志,1998,34(1):25-27. 被引量:13

二级参考文献3

  • 1Tang L D,J Pharm Sci,1994年,83卷,85页 被引量:1
  • 2陈祖基,实用眼科药理学,1993年,9页 被引量:1
  • 3黄恺,国外医学.皮肤性病学分册,1987年,13卷,4页 被引量:1

共引文献12

同被引文献46

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部